Cargando…

Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression

OBJECTIVE: Although several previous studies have examined the association between late-life depression and blood adipokine levels, a marker of chronic inflammation, no studies have comprehensively considered the effects of metabolic syndrome, which is known to affect blood adipokine levels. This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seung-Hoon, Shin, Cheolmin, Ko, Young-Hoon, Lee, Moon-Soo, Park, Moon Ho, Pae, Chi-Un, Yoon, Ho-Kyoung, Han, Changsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889913/ https://www.ncbi.nlm.nih.gov/pubmed/36700321 http://dx.doi.org/10.9758/cpn.2023.21.1.147

Ejemplares similares

Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data
por: Shin, Cheolmin, et al.
Publicado: (2019)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
por: Lee, Seung-Hoon, et al.
Publicado: (2022)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
por: Lee, Seung-Hoon, et al.
Publicado: (2022)

Assessment of life factors affecting the experience of depressive symptoms in adolescents: a secondary analysis using the Korea Youth Risk Behavior Survey
por: Lee, Jongha, et al.
Publicado: (2021)

Normative data and psychometric properties of the Patient Health Questionnaire-9 in a nationally representative Korean population
por: Shin, Cheolmin, et al.
Publicado: (2020)

Natural Course of Posttraumatic Symptoms in Late-Adolescent Maritime Disaster Survivors: Results of A 12-Month Follow-Up Study
por: Jeon, Sang Won, et al.
Publicado: (2018)

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2023)

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial
por: Kim, Junhyung, et al.
Publicado: (2023)

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders
por: Jeon, Sang Won, et al.
Publicado: (2017)

Pain and Depression: A Neurobiological Perspective of Their Relationship
por: Han, Changsu, et al.
Publicado: (2015)

Measurement-based Treatment of Residual Symptoms Using Clinically Useful Depression Outcome Scale: Korean Validation Study
por: Jeon, Sang Won, et al.
Publicado: (2017)

Experiences and barriers to implementation of clinical practice guideline for depression in Korea
por: Yang, Jaewon, et al.
Publicado: (2013)

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder
por: Shin, Cheolmin, et al.
Publicado: (2021)

Standardization of the Korean Version of the Patient Health Questionnaire-4 (PHQ-4)
por: Kim, Hyoun-Wook, et al.
Publicado: (2021)

Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale
por: Park, Sol A, et al.
Publicado: (2018)

Vilazodone for the Treatment of Depression: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice
por: Han, Changsu, et al.
Publicado: (2015)

Comorbid Zolpidem Dependence and Over-the-Counter Compound Analgesic Abuse
por: Kim, Hyounwook, et al.
Publicado: (2019)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting
por: Lee, Kyung Ho, et al.
Publicado: (2023)

Perspectives on the Happiness of Community-Dwelling Elderly in Korea
por: Jeon, Sang Won, et al.
Publicado: (2016)

Prevalence and Associated Factors of Depression in General Population of Korea: Results from the Korea National Health and Nutrition Examination Survey, 2014
por: Shin, Cheolmin, et al.
Publicado: (2017)

Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action
por: Wang, Sheng-Min, et al.
Publicado: (2015)

Impact of the COVID-19 Pandemic on Korean Adolescents' Mental Health and Lifestyle Factors
por: Lee, Jongha, et al.
Publicado: (2022)

Suicide and Suicide Prevention Awareness in Korea During the COVID-19 Pandemic
por: Lee, Jongha, et al.
Publicado: (2022)

Changes in Brain Electrical Activity According to Post-traumatic Stress Symptoms in Survivors of the Sewol Ferry Disaster: A 1-year Longitudinal Study
por: Jin, Sehee, et al.
Publicado: (2021)

PS156. Adjunctive brexpiprazole, a novel effective strategy for treating Major depressive disorder?: Systematic review and Meta-analysis
por: Yoon, Seoyoung, et al.
Publicado: (2016)

Insomnia in Emotional Labor: Its Role in Autonomic Nervous System Regulation
por: Chae, Boram, et al.
Publicado: (2021)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2019)

Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice
por: Lee, Kyung Ho, et al.
Publicado: (2020)

The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study
por: Han, Changsu, et al.
Publicado: (2019)

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial
por: Shin, Cheolmin, et al.
Publicado: (2020)

Relationship between Depression and Laryngopharyngeal Reflux
por: Joo, Young-Hoon, et al.
Publicado: (2017)

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises
por: Pae, Chi-Un, et al.
Publicado: (2014)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

Do Somatic Symptoms Predict the Severity of Depression? A Validation Study of the Korean Version of the Depression and Somatic Symptoms Scale
por: Jeon, Sang Won, et al.
Publicado: (2016)

Standardization of the Korean Version of the Posttraumatic Embitterment Disorder Self-Rating Scale
por: Shin, Cheolmin, et al.
Publicado: (2012)

Evaluation of an eight marker-panel including long mononucleotide repeat markers to detect microsatellite instability in colorectal, gastric, and endometrial cancers
por: Chung, Yousun, et al.
Publicado: (2023)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
por: Kim, Sam-Moon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jg5fcuj2u7oub4lfqa0bj4onbq